Access cutting-edge peritoneal mesothelioma treatment through this clinical trial at a research site in Lexington. Study-provided care at no cost to qualified participants.
Access peritoneal mesothelioma specialists in Lexington at no cost
This study follows strict safety protocols and ethical guidelines
All study-related peritoneal mesothelioma treatment provided free
This phase II trial compares the usual treatment alone (carboplatin, pemetrexed, and bevacizumab) to using immunotherapy (atezolizumab) plus the usual treatment in treating patients with peritoneal mesothelioma. The usual treatment consists of surgery or chemotherapy. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slow
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this peritoneal mesothelioma clinical trial in Lexington, KY
If you're searching for peritoneal mesothelioma treatment options in Lexington, KY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lexington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced peritoneal mesothelioma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.